Literature DB >> 25645922

Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Renu Wadhwa1, Jihoon Ryu2, Hyo Min Ahn2, Nishant Saxena1, Anupama Chaudhary1, Chae-Ok Yun3, Sunil C Kaul4.   

Abstract

Mortalin/mtHsp70/Grp75 (mot-2), a heat shock protein 70 family member, is an essential chaperone, enriched in cancers, and has been shown to possess pro-proliferative and anti-apoptosis functions. An allelic form of mouse mortalin (mot-1) that differs by two amino acids, M618V and G624R, in the C terminus substrate-binding domain has been reported. Furthermore, genome sequencing of mortalin from Parkinson disease patients identified two missense mutants, R126W and P509S. In the present study, we investigated the significance of these mutations in survival, proliferation, and oxidative stress tolerance in human cells. Using mot-1 and mot-2 recombinant proteins and specific antibodies, we performed screening to find their binding proteins and then identified ribosomal protein L-7 (RPL-7) and elongation factor-1 α (EF-1α), which differentially bind to mot-1 and mot-2, respectively. We demonstrate that mot-1, R126W, or P509S mutant (i) lacks mot-2 functions involved in carcinogenesis, such as p53 inactivation and hTERT/hnRNP-K (heterogeneous nuclear ribonucleoprotein K) activation; (ii) causes increased level of endogenous oxidative stress; (iii) results in decreased tolerance of cells to exogenous oxidative stress; and (iv) shows differential binding and impact on the RPL-7 and EF-1α proteins. These factors may mediate the transformation of longevity/pro-proliferative function of mot-2 to the premature aging/anti-proliferative effect of mutants, and hence may have significance in cellular aging, Parkinson disease pathology, and prognosis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  70-kilodalton Heat Shock Protein (Hsp70); EF-1alpha; Mechanism; Mortalin; Oxidative Stress; Parkinson Disease; Point Mutation; Proliferation; Protein-Protein Interaction; RPL-7; Senescence

Mesh:

Substances:

Year:  2015        PMID: 25645922      PMCID: PMC4375496          DOI: 10.1074/jbc.M114.627463

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Role of oxidative stress in telomere length regulation and replicative senescence.

Authors:  T von Zglinicki
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

2.  The putative helical lid of the Hsp70 peptide-binding domain is required for efficient preprotein translocation into mitochondria.

Authors:  Andreas Strub; Nicole Zufall; Wolfgang Voos
Journal:  J Mol Biol       Date:  2003-12-12       Impact factor: 5.469

Review 3.  Elongation factor 1 alpha, translation and the cytoskeleton.

Authors:  J Condeelis
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

Review 4.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

5.  Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.

Authors:  Mu-Shui Dai; Kishore B Challagundla; Xiao-Xin Sun; Lakshmi Reddy Palam; Shelya X Zeng; Ronald C Wek; Hua Lu
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

6.  Transcriptional inactivation of p53 by deletions and single amino acid changes in mouse mot-1 protein.

Authors:  S C Kaul; S Takano; R R Reddel; Y Mitsui; R Wadhwa
Journal:  Biochem Biophys Res Commun       Date:  2000-12-20       Impact factor: 3.575

7.  A proteomic screen with Drosophila Opa1-like identifies Hsc70-5/Mortalin as a regulator of mitochondrial morphology and cellular homeostasis.

Authors:  Shamik Banerjee; Balaji Chinthapalli
Journal:  Int J Biochem Cell Biol       Date:  2014-07-01       Impact factor: 5.085

8.  Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility.

Authors:  Luisa Pecorari; Oriano Marin; Chiara Silvestri; Olivia Candini; Elena Rossi; Clara Guerzoni; Sara Cattelani; Samanta A Mariani; Francesca Corradini; Giovanna Ferrari-Amorotti; Laura Cortesi; Rita Bussolari; Giuseppe Raschellà; Massimo R Federico; Bruno Calabretta
Journal:  Mol Cancer       Date:  2009-08-03       Impact factor: 27.401

9.  Identification and functional characterization of nuclear mortalin in human carcinogenesis.

Authors:  Jihoon Ryu; Zeenia Kaul; A-Rum Yoon; Ye Liu; Tomoko Yaguchi; Youjin Na; Hyo Min Ahn; Ran Gao; Il-Kyu Choi; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

10.  Structural and functional properties of ribosomal protein L7 from humans and rodents.

Authors:  P Hemmerich; A von Mikecz; F Neumann; O Sözeri; G Wolff-Vorbeck; R Zoebelein; U Krawinkel
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

View more
  21 in total

1.  Biophysical Consequences of EVEN-PLUS Syndrome Mutations for the Function of Mortalin.

Authors:  Mitchell A Moseng; Jay C Nix; Richard C Page
Journal:  J Phys Chem B       Date:  2019-04-12       Impact factor: 2.991

Review 2.  The mitochondrial PKCδ/retinol signal complex exerts real-time control on energy homeostasis.

Authors:  Youn-Kyung Kim; Ulrich Hammerling
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-10       Impact factor: 4.698

3.  Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.

Authors:  Genevieve Beauvais; Nicole M Bode; Jaime L Watson; Hsiang Wen; Kevin A Glenn; Hiroyuki Kawano; N Charles Harata; Michelle E Ehrlich; Pedro Gonzalez-Alegre
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

4.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

5.  Relevance of mortalin to cancer cell stemness and cancer therapy.

Authors:  Chae-Ok Yun; Priyanshu Bhargava; Youjin Na; Jung-Sun Lee; Jihoon Ryu; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

Review 6.  Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.

Authors:  Sanam Sane; Khosrow Rezvani
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

Review 7.  Protein misfolding in neurodegenerative diseases: implications and strategies.

Authors:  Patrick Sweeney; Hyunsun Park; Marc Baumann; John Dunlop; Judith Frydman; Ron Kopito; Alexander McCampbell; Gabrielle Leblanc; Anjli Venkateswaran; Antti Nurmi; Robert Hodgson
Journal:  Transl Neurodegener       Date:  2017-03-13       Impact factor: 8.014

Review 8.  Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.

Authors:  Erik L Friesen; Mitch L De Snoo; Luckshi Rajendran; Lorraine V Kalia; Suneil K Kalia
Journal:  Parkinsons Dis       Date:  2017-08-21

9.  Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.

Authors:  Beryl Royer-Bertrand; Silvia Castillo-Taucher; Rodrigo Moreno-Salinas; Tae-Joon Cho; Jong-Hee Chae; Murim Choi; Ok-Hwa Kim; Esra Dikoglu; Belinda Campos-Xavier; Enrico Girardi; Giulio Superti-Furga; Luisa Bonafé; Carlo Rivolta; Sheila Unger; Andrea Superti-Furga
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

10.  Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.

Authors:  Srinivas Ayyadevara; Meenakshisundaram Balasubramaniam; Paul A Parcon; Steven W Barger; W Sue T Griffin; Ramani Alla; Alan J Tackett; Samuel G Mackintosh; Emanuel Petricoin; Weidong Zhou; Robert J Shmookler Reis
Journal:  Aging Cell       Date:  2016-07-23       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.